The Effects of Opium Addiction on the Immune System Function in Patients with Fungal Infection

Seyyed Amin Ayatollahi-Mousavi, Gholamreza Asadikaram, Nouzar Nakhaee, Alireza Izadi, Nasser Keikha

Abstract


Background: The use of narcotics such as opium exposes addicts as susceptible targets of different diseases so that they might easily be exposed to different diseases such as fungal infections. The present study aimed to investigate the effects of addiction to opium and fungal infection on plasma levels of certain cytokines including interleukin-4 (IL-4), IL-6, IL-17, Interferon gamma (IFN-γ) and transforming growth factor-β (TGF-β).

Methods: Present study included 72 individuals who were divided into 4 groups: 1) opium-addicted with fungal infection; 2) opium-addicted without fungal infection; 3) non-opium-addicted with fungal infection; and 4) normal individuals (non-opium-addicted and non-fungal infection). The fungal samples, after being detected and confirmed by a physician, were prepared based on clinical symptoms and then analyzed by direct smear and culture method. The measurement of the plasma level of cytokines was done by enzyme-linked immunosorbent assay (ELISA) method.

Findings: The comparison of the mean of the plasma level of cytokines showed that addiction to opium and fungal infection had significant effect on the plasma levels of IL-17, IFN-γ, TGF-β cytokines in all studied groups. The interaction of addiction to opium and fungal infection was only significant in the case of plasma level of IL-6.

Conclusion: Addiction to opium and fungal infection, either separately or simultaneously, poses significant effect on the immune system and causes disorders in the cytokine network and the immune system and also provides a suitable environment for fungal infection.


Keywords


Opium; Addiction; Fungal infection; Cytokine

Full Text:

PDF

References


Ghazavi A, Solhi H, Moazzeni SM, Rafiei M, Mosayebi G. Cytokine profiles in long-term smokers of opium (Taryak). J Addict Med 2013; 7(3): 200-3.

Nakhaee N, Divsalar K, Meimandi MS, Dabiri S. Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran. Subst Use Misuse 2008; 43(3-4): 513-20.

Ziaaddini H, Ziaaddini M. The household survey of drug abuse in Kerman, Iran. J Appl Sci 2005; 5(2): 380-2.

Karam GA, Rashidinejad HR, Aghaee MM, Ahmadi J, Rahmani MR, Mahmoodi M, et al. Opium can differently alter blood glucose, sodium and potassium in male and female rats. Pak J Pharm Sci 2008; 21(2): 180-4.

Igder S, Asadikaram GR, Sheykholeslam F, Sayadi AR, Mahmoodi M, Kazemi AM, et al. Opium induces apoptosis in jurkat cells. Addict Health 2013; 5(1-2): 27-34.

Saadat H, Ziai SA, Ghanemnia M, Namazi MH, Safi M, Vakili H, et al. Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients. PLoS One 2012; 7(9): e44939.

Boland JW, Foulds GA, Ahmedzai SH, Pockley AG. A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function. BMJ Support Palliat Care 2014; 4(4): 357-67.

Lutz PE, Kieffer BL. Opioid receptors: distinct roles in mood disorders. Trends Neurosci 2013; 36(3): 195-206.

Roy S, Wang J, Kelschenbach J, Koodie L, Martin J. Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol 2006; 1(1): 77-89.

Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol 2004; 9(1): 53-8.

Singhal PC, Kapasi AA, Franki N, Reddy K. Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology 2000; 100(1): 57-62.

Amsterdam A, Sasson R, Keren-Tal I, Aharoni D, Dantes A, Rimon E, et al. Alternative pathways of ovarian apoptosis: death for life. Biochem Pharmacol 2003; 66(8): 1355-62.

Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol 2005; 129(5): 569-82.

Bisbe J, Miro JM, Latorre X, Moreno A, Mallolas J, Gatell JM, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 1992; 15(6): 910-23.

Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11(4): 275-88.

Romani L, Puccetti P, Bistoni F. Biological role of Th cell subsets in candidiasis. Chem Immunol 1996; 63: 115-37.

Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4(1): 11-24.

Mencacci A, Cenci E, Bacci A, Montagnoli C, Bistoni F, Romani L. Cytokines in candidiasis and aspergillosis. Curr Pharm Biotechnol 2000; 1(3): 235-51.

Wang Y, Wang X, Ye L, Li J, Song L, Fulambarkar N, et al. Morphine suppresses IFN signaling pathway and enhances AIDS virus infection. PLoS One 2012; 7(2): e31167.

Crameri R, Blaser K. Allergy and immunity to fungal infections and colonization. Eur Respir J 2002; 19(1): 151-7.

Clemons KV, Stevens DA. Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy. Semin Respir Infect 2001; 16(1): 60-6.

Asadikaram G, Asiabanha M, Sayadi A, Jafarzadeh A, Hassanshahi G. Impact of opium on the serum levels of TGF-beta in diabetic, addicted and addicted-diabetic rats. Iran J Immunol 2010; 7(3): 186-92.

Finley MJ, Happel CM, Kaminsky DE, Rogers TJ. Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression. Cell Immunol 2008; 252(1-2): 146-54.

Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13(2): 139-45.

Nabati S, Asadikaram G, Arababadi MK, Shahabinejad G, Rezaeian M, Mahmoodi M, et al. The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes. Immunol Lett 2013; 152(1): 42-6.

Shellito JE, Tate C, Ruan S, Kolls J. Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii. J Infect Dis 2000; 181(6): 2011-7.

Aydogan K, Tore O, Akcaglar S, Oral B, Ener B, Tunali S, et al. Effects of Malassezia yeasts on serum Th1 and Th2 cytokines in patients with guttate psoriasis. Int J Dermatol 2013; 52(1): 46-52.

Blanco JL, Garcia ME. Immune response to fungal infections. Vet Immunol Immunopathol 2008; 125(1-2): 47-70.

Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996; 131(12): 1303-8.

Romani L, Bistoni F, Puccetti P. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol 2002; 10(11): 508-14.

Ashman RB, Papadimitriou JM. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 1995; 59(4): 646-72.

Asadikaram G, Eigder S, Kazemi-Arababadi M, Mahmoodi M. The effects of different concentration of opium on the secretion of TGF-β in Jurkat cells. Clinical Biochemistry 2011; 44(13): S134-S135.

Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206(2): 299-311.

Lilly EA, Hart DJ, Leigh JE, Hager S, McNulty KM, Mercante DE, et al. Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis. J Infect Dis 2004; 190(3): 605-12.

Schaller M, Boeld U, Oberbauer S, Hamm G, Hube B, Korting HC. Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 2004; 150(Pt 9): 2807-13.




DOI: http://dx.doi.org/10.22122/ahj.v8i4.422

Refbacks

  • There are currently no refbacks.